Clinical Trial Update: Intravenous L-Citrulline Influence on the Need for Invasive Mechanical Ventilation for Acute Hypoxemic Respiratory Failure in Patients With COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 trial assessing intravenous L-Citrulline to influence the need for invasive mechanical ventilation in acute hypoxemic respiratory failure due to COVID-1…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxemic Respiratory Failure

Drugs mentioned

• L-Citrulline (intravenous) (L-Citrulline)

Snippet

Sponsor: Asklepion Pharmaceuticals, LLC | Conditions: Acute Hypoxemic Respiratory Failure | Phase 2 | Status: COMPLETED | Results posted: 2023-02-22